Skip to main content

Table 1 IC50 Values of 11 cell lines using Trial Drug (DAAD2)

From: Synthesis and bio-molecular study of (+)-N-Acetyl-α-amino acid dehydroabietylamine derivative for the selective therapy of hepatocellular carcinoma

Cell Lines IC50 Value of DAAD2
(μM conc.)
R2
Hep3B 2.0 ± 0.4 0.9
MCF7 2.2 ± 0.8 0.8
PLC 2.8 ± 0.6 0.9
Hep3B-TR 3.2 ± 0.8 0.8
Hep40 3.5 ± 1 0.8
SNU387 3.6 ± 0.6 0.8
SNU475 4.4 ± 0.6 0.7
Mahlavu 5.2 ± 0.9 0.6
Huh7 6.4 ± 2 0.6
HepG2 7.6 ± 0.8 0.5
SNU449 27.5 ± 5 0.7